Next Article in Journal
Proteomic Workflows for Biomarker Identification Using Mass Spectrometry — Technical and Statistical Considerations during Initial Discovery
Next Article in Special Issue
The Role of Translational Regulation in Survival after Radiation Damage; an Opportunity for Proteomics Analysis
Previous Article in Journal / Special Issue
Impact of Solar Radiation on Gene Expression in Bacteria
Open AccessReview

Exosomal Proteome Profiling: A Potential Multi-Marker Cellular Phenotyping Tool to Characterize Hypoxia-Induced Radiation Resistance in Breast Cancer

1
Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
2
Eli Lilly and Company, Indianapolis, IN 46285, USA
3
Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD 21201, USA
4
Division of Oncology, University of Maryland School of Dentistry, Baltimore, MD 21201, USA
5
Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
6
Oncology and Diagnostic Sciences, University of Maryland School of Dentistry, Baltimore, MD 21201, USA
7
Department of Molecular Pharmacology, Beckman Research Institute, City of Hope, Duarte, CA 91010, USA
8
Irell and Manella Graduate School of Biological Sciences, Beckman Research Institute, City of Hope, Duarte, CA 91010, USA
9
Department of Radiation Oncology, University of California, Irvine, CA 92697, USA
10
Department of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, MD 21201, USA
*
Author to whom correspondence should be addressed.
Proteomes 2013, 1(2), 87-108; https://doi.org/10.3390/proteomes1020087
Received: 17 June 2013 / Revised: 16 July 2013 / Accepted: 30 July 2013 / Published: 9 August 2013
(This article belongs to the Special Issue Radiation Proteomics)
Radiation and drug resistance are significant challenges in the treatment of locally advanced, recurrent and metastatic breast cancer that contribute to mortality. Clinically, radiotherapy requires oxygen to generate cytotoxic free radicals that cause DNA damage and allow that damage to become fixed in the genome rather than repaired. However, approximately 40% of all breast cancers have hypoxic tumor microenvironments that render cancer cells significantly more resistant to irradiation. Hypoxic stimuli trigger changes in the cell death/survival pathway that lead to increased cellular radiation resistance. As a result, the development of noninvasive strategies to assess tumor hypoxia in breast cancer has recently received considerable attention. Exosomes are secreted nanovesicles that have roles in paracrine signaling during breast tumor progression, including tumor-stromal interactions, activation of proliferative pathways and immunosuppression. The recent development of protocols to isolate and purify exosomes, as well as advances in mass spectrometry-based proteomics have facilitated the comprehensive analysis of exosome content and function. Using these tools, studies have demonstrated that the proteome profiles of tumor-derived exosomes are indicative of the oxygenation status of patient tumors. They have also demonstrated that exosome signaling pathways are potentially targetable drivers of hypoxia-dependent intercellular signaling during tumorigenesis. This article provides an overview of how proteomic tools can be effectively used to characterize exosomes and elucidate fundamental signaling pathways and survival mechanisms underlying hypoxia-mediated radiation resistance in breast cancer. View Full-Text
Keywords: hypoxia; radiation; breast cancer; tumor microenvironment; exosomes; proteomics hypoxia; radiation; breast cancer; tumor microenvironment; exosomes; proteomics
Show Figures

Figure 1

MDPI and ACS Style

Thomas, S.N.; Liao, Z.; Clark, D.; Chen, Y.; Samadani, R.; Mao, L.; Ann, D.K.; Baulch, J.E.; Shapiro, P.; Yang, A.J. Exosomal Proteome Profiling: A Potential Multi-Marker Cellular Phenotyping Tool to Characterize Hypoxia-Induced Radiation Resistance in Breast Cancer. Proteomes 2013, 1, 87-108. https://doi.org/10.3390/proteomes1020087

AMA Style

Thomas SN, Liao Z, Clark D, Chen Y, Samadani R, Mao L, Ann DK, Baulch JE, Shapiro P, Yang AJ. Exosomal Proteome Profiling: A Potential Multi-Marker Cellular Phenotyping Tool to Characterize Hypoxia-Induced Radiation Resistance in Breast Cancer. Proteomes. 2013; 1(2):87-108. https://doi.org/10.3390/proteomes1020087

Chicago/Turabian Style

Thomas, Stefani N.; Liao, Zhongping; Clark, David; Chen, Yangyi; Samadani, Ramin; Mao, Li; Ann, David K.; Baulch, Janet E.; Shapiro, Paul; Yang, Austin J. 2013. "Exosomal Proteome Profiling: A Potential Multi-Marker Cellular Phenotyping Tool to Characterize Hypoxia-Induced Radiation Resistance in Breast Cancer" Proteomes 1, no. 2: 87-108. https://doi.org/10.3390/proteomes1020087

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Search more from Scilit
 
Search
Back to TopTop